← Eichor
Study identifier: NCT05674487 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN)

Condition: Fetal Growth Restriction  ·  Sponsor: University Hospital, Bordeaux

PhaseNA
Planned participants774
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this randomized trial is to compare two methods of induction in a fetal growth restriction population. The main question it aims to answer is: • Is trans-cervical balloon superior to prostaglandins in reducing the cesarean section rate, without increasing neonatal morbidity? Participants will have an induction of labour by cervical ripening with trans-cervical balloon in the trans-cervical balloon catheter arm and with Prostaglandins in the Misoprostol arm. Researchers will compare two methods of induction: trans-cervical balloon and prostaglandins to see if trans-cervical balloon is associated with a lower risk of cesarean delivery.

This description comes directly from the study's public registry record.

Talk to the study team

Hanane Bouchghoul, MD  ·  +335 57 82 16 12  ·  hanane.bouchghoul@chu-bordeaux.fr

Loic Sentilhes, MD, PhD  ·  loic.sentilhes@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU BordeauxBordeaux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05674487